title: Endocrine complications following pediatric bone marrow transplantation.
abstract: Pediatric bone marrow transplantation (BMT) for various diseases can lead to endocrine system dysfunction owing to preparative regimens involving chemotherapy and radiation therapy. We assessed the prevalence of post-BMT endocrine complications in children treated at the Alberta Children's Hospital (ACH) from 1991 to 2001. Time of onset of endocrine dysfunction, underlying disease processes, chemotherapy, radiation therapy and age at BMT were characterized. Subjects of <18 years of age at the time of allogeneic or autologous BMT for whom 1-year follow-up through the ACH and a chart were available for review were included in the study. Subjects with a pre-existing endocrine condition were excluded. Of the 194 pediatric BMT procedures performed at the ACH between January 1, 1991 and December 31, 2001, 150 complete charts were available for review. Sixty five subjects received follow-up care at other centers and were excluded. Therefore, a total of 85 subjects were included in the review. The prevalence of endocrine complications identified was: primary hypothyroidism 1.2%, compensated hypothyroidism 7.0%, hyperthyroidism 2.4%, hypergonadotrophic hypogonadism 22.4%, abnormal bone density 2.4%, and secondary diabetes mellitus 1.2%. These findings emphasize the need to screen for endocrine system dysfunction, particularly hypergonadotrophic hypogonadism, in children who have undergone BMT. Children need long-term follow-up so that endocrine complications can be diagnosed and treated promptly.
authors.affiliation: Division of Endocrinology, Department of Pediatrics, Alberta Children's Hospital, Calgary, Alberta T3B 6A8, Canada. josephine.ho@albertahealthservices.ca
authors.forename: Josephine
authors.initials: J
authors.lastname: Ho
authors.forename: Victor
authors.initials: V
authors.lastname: Lewis
authors.forename: Gregory M T
authors.initials: GM
authors.lastname: Guilcher
authors.forename: David K
authors.initials: DK
authors.lastname: Stephure
authors.forename: Danièle
authors.initials: D
authors.lastname: Pacaud
mesh_terms: D000293:Adolescent; D000416:Alberta; D000970:Antineoplastic Agents / Q000009:adverse effects; D015519:Bone Density; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003920:Diabetes Mellitus / Q000209:etiology; D004700:Endocrine System Diseases / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology; D007006:Hypogonadism / Q000209:etiology; D007037:Hypothyroidism / Q000209:etiology; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011832:Radiation Injuries / Q000209:etiology; D012189:Retrospective Studies; D019172:Transplantation Conditioning / Q000009:adverse effects
chemical_list: D000970:Antineoplastic Agents